Zhongfeng Xingnao Decoction(ZFXN)has been utilized for treating intracerebral hemorrhage(ICH)in China,while the pharmacological mechanism of ZFXN remains unclear.Exploring the pharmacological roles of ZFXN is critical for guiding the treat-ment of cerebrovascular diseases.In this study,a rat model of ICH was constructed by injection of Ⅶ collagenase in the right caudate nucleus.SD rats were randomly assigned into five groups,and the neurological function of rats was evaluated based on the Bederson score.Magnetic resonance imaging(MRI)was used to assess the volume of ICH.Hematoxylin-eosin(HE)staining and transmission electron microscopy(TEM)were employed to observe the pathological and ultrastructural changes in the brain tissue.The levels of re-active oxygen species(ROS)were measured by flow cytometry.The immunofluorescence assay was employed to detect the expression of glutathione peroxidase 4(GPX4)in neurons surrounding the hematoma.Finally,Western blot was employed to determine the ex-pression of ferroptosis-related proteins upstream frameshift 1(UPF1),ferroportin(FPN),acyl-CoA ligase 4(ACSL4),cyclooxyge-nase-2(COX-2),GPX4,NADPH oxidase 1(NOX1),and solute carrier family 7 member 11(SLC7A11)after ICH.Compared with the model(ICH)group,ZFXN treatment for 5 days attenuated neurological dysfunction,reduced the hematoma volume,and alleviated the pathological changes induced by ICH.Meanwhile,ZFXN lowered the levels of Fe2+and oxidative stress and up-regulated the ex-pression of proteins inhibiting ferroptosis.ZFXN improved the prognosis of ICH in rats by inhibiting neuronal ferroptosis,which provided a valuable guide for the clinical application of ZFXN.ZFXN may inhibit ferroptosis by promoting the expression of SLC7A11 and FPN.
intracerebral hemorrhageferroptosisZhongfeng Xingnao Decoctionneuronal death
NETL
NSTL
万方数据
